Our mission

End age-related chronic disease

Vero is a predictive health company on a mission to end age related chronic disease. Vero uses proteomics and AI to measure organ and cellular health from a single blood draw. The test is the entry point to Vero Compass, a biological intelligence platform that guides precision interventions, measures whether those interventions are working, and predicts where an individual’s health is heading.

We’re working with clinicians, researchers and partners to move healthcare from reactive to predictive by understanding what drives aging at the organ and cellular level.

Partner with us
Our people

Founding Team

Tony Wyss-Coray
Tony Wyss-Coray, PhD
Co-Founder

D.H. Chen Distinguished Professor of Neurology and Neurological Sciences at Stanford.

Paul Coletta
Paul Coletta
CEO & Co-Founder

30 years of experience building consumer brands for companies like Disney, HP, Viacom and Urban Remedy.

Markus Okumus
Markus Okumus
Co-Founder

30 years founding and building consumer and health companies across the US and Europe — from first idea to exit.

Early access

Discover your OrganAge™

Join our waitlist to get priority access to OrganAge™ and Vero Compass™ as they become more widely available.

Get early accessPartner with Vero